Larvol Delta - AmMax-Bio-Announces-Presentation-of-Phase-2-PKPD-Data-of-ABM05X-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT-at-ESMO-Congress-2022

AMB-05X - AmMax

https://www.globenewswire.com/news-release/2022/09/12/2513967/0/en/AmMax-Bio-Announces-Presentation-of-Phase-2-PK-PD-Data-of-ABM-05X-for-the-Treatment-of-Tenosynovial-Giant-Cell-Tumor-TGCT-at-ESMO-Congress-2022.html

Sep 12, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next